BCDA - BioCardia, Inc.

QQQ $ 429.07 $ 5.38 (1.28 %)

DIA $ 382.31 $ 3.34 (0.88 %)

SPY $ 505.01 $ 4.68 (0.94 %)

TLT $ 88.87 $ 0.38 (0.43 %)

GLD $ 213.12 $ -0.66 (-0.31 %)

Previous Close

$ 0.375

Open

$ 0.39

Bid

$ 0.00 x 0

Ask

$ 0.39 x 100

Day's Range

$ 0.38 - $ 0.39

52 Week Range

$ 0.32 - $ 2.92

Volume

201,393

Average Volume

Market Cap

10.02M

Beta (5Y Monthly)

$ 0.41

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-27-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-09-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	03-29-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	08-10-2022	06-30-2022	10-Q
8	05-11-2022	03-31-2022	10-Q
9	03-29-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-12-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	03-30-2021	12-31-2020	10-K
14	11-10-2020	09-30-2020	10-Q
15	08-13-2020	06-30-2020	10-Q
16	05-15-2020	03-31-2020	10-Q
17	04-09-2020	12-31-2019	10-K
18	11-19-2019	09-30-2019	10-Q
19	08-14-2019	06-30-2019	10-Q
20	05-15-2019	03-31-2019	10-Q
21	04-02-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-10-2018	03-31-2018	10-Q
25	03-16-2018	12-31-2017	10-K
26	11-09-2017	09-30-2017	10-Q
27	08-14-2017	06-30-2017	10-Q
28	05-11-2017	03-31-2017	10-Q
29	03-30-2017	12-31-2016	10-K
30	10-17-2016	09-30-2016	10-Q
31	08-02-2016	06-30-2016	10-Q
32	05-03-2016	03-31-2016	10-Q
33	03-25-2016	12-31-2015	10-K
34	10-29-2015	09-30-2015	10-Q
35	08-12-2015	06-30-2015	10-Q
36	05-12-2015	03-31-2015	10-Q
37	03-24-2015	12-31-2014	10-K
38	11-06-2014	09-30-2014	10-Q
39	08-06-2014	06-30-2014	10-Q
40	05-12-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

BioCardia Announced The Primary Endpoint R...
05/01/2024 11:16:29

$biocardia-announces-results-from-open-label-roll-in-cohort-of-patients-having-chronic-myocardial-ischemia-with-refractory-angina-showed-avg-increase-in-exercise-tolerance-of-107-seconds-and-an-avg--of-82-reduction-in-angina-episodes-at-the-primary-six-month-follow-up-endpoint$

BioCardia Announces Results From Open Labe...
05/01/2024 11:15:51

BioCardia Completes Enrollment Of CardiAMP...
04/25/2024 13:01:43